Publications of R. Landgraf
All genres
Journal Article (250)
101.
Journal Article
40 (5), pp. 231 - 232 (2007)
15N metabolic labeling of high and low anxiety-related behavior HAB/LAB mice. Pharmacopsychiatry 102.
Journal Article
40 (5), p. 218 - 218 (2007)
Linking cognitive abilities and stress reactivity: insights from the HR/IR/LR mouse model. Pharmacopsychiatry 103.
Journal Article
16 (1), pp. 64 - 70 (2007)
Neural nitric oxide gene inactivation affects the release profile of oxytocin into the blood in response to forced swimming. Nitric Oxide-Biology and Chemistry 104.
Journal Article
61 (6), p. 497 - 497 (2007)
Neuropetide Y, calcitonin gene-related peptide and CRH in brain of rats bred for high anxiety-related behaviors. Nordic Journal of Psychiatry 105.
Journal Article
31 (1), pp. 89 - 102 (2007)
Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: Focus on vasopressin and glyoxalase-I. Neuroscience and Biobehavioral Reviews 106.
Journal Article
27 (4), pp. 832 - 839 (2007)
Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. The Journal of Neuroscience 107.
Journal Article
61, pp. 782 - 796 (2007)
Altered brain activation pattern associated with drug-induced attenuation of enhanced depression-like behavior in rats bred for high anxiety. Biological Psychiatry 108.
Journal Article
31 (12), pp. 2573 - 2579 (2006)
Temazepam triggers the release of vasopressin into the rat hypothalamic paraventricular nucleus: Novel insight into benzodiazepine action on hypothalamic-pituitary-adrenocortical system activity during stress. Neuropsychopharmacology 109.
Journal Article
5 (10), pp. 1914 - 1920 (2006)
Protein biomarkers in a mouse model of extremes in trait anxiety. Molecular & Cellular Proteomics 110.
Journal Article
31 (3), pp. 211 - 213 (2006)
Neuropeptides in anxiety and depression. Amino Acids 111.
Journal Article
31 (6), pp. 724 - 735 (2006)
Altered hypothalamo-pituitary-adrenal and sympatho-adrenomedullary activities in rats bred for high anxiety: central and peripheral correlates. Psychoneuroendocrinology 112.
Journal Article
9 (Suppl. 1), p. S46 - S46 (2006)
Neurobiological correlates of pathological anxiety studied in psychopathological rodent models. International Journal of Neuropsychopharmacology 113.
Journal Article
50 (8), pp. 1048 - 1058 (2006)
Airjet and FG-7142-induced Fos expression differs in rats selectively bred for high and low anxiety-related behavior. Neuropharmacology 114.
Journal Article
120 (3), pp. 719 - 723 (2006)
Confinement to the open arm of the elevated-plus maze as anxiety paradigm: Behavioral validation. Behavioral Neuroscience 115.
Journal Article
40 (2), pp. 142 - 143 (2006)
The brain vasopressin system is a final common pathway in trait anxiety and depression-like behavior. Neuropeptides 116.
Journal Article
372 (Suppl. 1), p. 79 - 79 (2006)
Reduced depression-like behavior in HAB rats after NK1-receptor antagonist treatment is associated with an altered neuronal activation pattern in specific brain areas. Naunyn-Schmiedebergs Archives of Pharmacology 117.
Journal Article
120 (1), pp. 60 - 71 (2006)
Genetic predisposition to anxiety-related behavior determines coping style, neuroendocrine responses, and neuronal activation during social defeat. Behavioral Neuroscience 118.
Journal Article
50, pp. 496 - 501 (2006)
Effects of Morris water maze testing on the neuroendocrine stress response and intrahypothalamic release of vasopressin and oxytocin in the rat. Hormones and Behavior 119.
Journal Article
15 (Suppl. 3), pp. S347 - S348 (2005)
Candidate genes of anxiety and depression: from mice and rats to men. European Neuropsychopharmacology 120.
Journal Article
31 (5), doi: 10.1038/sj.npp.1300910, pp. 925 - 932 (2005)
Anxiety and hippocampus volume in the rat. Neuropsychopharmacology